Impact fact

Sean has led projects supporting more than 25 pharmaceutical launches and developed forecasts for more than 30 inline and pipeline products.


Sean has been with ZS since 2006 and currently leads the Los Angeles office and the firm’s forecasting practice. He is a frequent collaborator with practice teams focused on oncology and rare diseases, and is a facilitator for ZS’s unconscious bias program.




Sean works with ZS’s life sciences clients to help guide them in making a broad array of sales, marketing and business development decisions that commonly depend upon business forecasts or insights drawn from forecasted market dynamics. He integrates into his work a wide array of analytical and primary research methodologies to ensure decisions are grounded in a deep understanding of markets.



Prior experience

Before joining ZS, Sean led business development for a discovery-stage pharmaceutical company that was using machine learning and machine vision methods to develop novel treatments for heart failure. He also worked with a boutique consultancy providing strategy and marketing support to early stage high-tech and life sciences companies.




Sean holds an MBA with distinction from the Kellogg School of Management at Northwestern University, and a B.A. (cum laude) from Williams College. He is a co-inventor on U.S. patent 9,001,884, describing novel methods for analytically characterizing digital image sequences and their applications in life sciences microscopy.



Media coverage